Nano-X Imaging (NNOX) Income from Non-Controlling Interests (2021 - 2025)
Nano-X Imaging (NNOX) posted quarterly Income from Non-Controlling Interests of $4000.0 for Q2 2025, down 93.94% year-on-year from $66000.0 in Q2 2024, and up 300.0% on a QoQ basis from -$2000.0 in Q1 2025.
Nano-X Imaging (NNOX) Income from Non-Controlling Interests (2021 - 2025) Analysis & Trends
Nano-X Imaging (NNOX) has reported Income from Non-Controlling Interests for 5 consecutive years, with $4000.0 the latest figure, recorded in Q2 2025.
- Quarterly Income from Non-Controlling Interests fell 93.94% year-over-year to $4000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $130000.0 (down 88.86% YoY) and the FY2022 annual result came in at -$1.4 million, down 125.21% from the prior year.
- Income from Non-Controlling Interests grew to $4000.0 in Q2 2025 per NNOX's latest filing, from -$2000.0 in the prior quarter.
- Over the last five years, Income from Non-Controlling Interests for NNOX reached as high as $545000.0 in Q3 2023 and fell as low as -$1.4 million in Q1 2022.
- A 5-year average of -$18214.3 and a median of $33000.0 in 2024 frame the typical range for Income from Non-Controlling Interests.
- Annual changes were most pronounced in 2022 — Income from Non-Controlling Interests plunged 104.31% — and 2023, when it jumped 314.57%.
- Year by year, Income from Non-Controlling Interests stood at -$417000.0 in 2021, then soared by 216.31% to $485000.0 in 2022, then grew by 12.37% to $545000.0 in 2023, then tumbled by 88.62% to $62000.0 in 2024, then slumped by 93.55% to $4000.0 in 2025.
- According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered $4000.0, -$2000.0, and $62000.0 for Q2 2025, Q1 2025, and Q3 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.32 Bn | 177.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.88 Bn | 99.66 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 68.65 Bn | 67.20 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 47.43 Bn | 43.76 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.48 Bn | 26.19 Bn | 1.98 Bn | 22.00 Mn |
| 7 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 26.98 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | -5.85 Mn |
| 10 | Nano-X Imaging | 64,014.67 | -44.16 Mn | -2.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 4,000.00 |
| Mar 31, 2025 | -2,000.00 |
| Sep 30, 2024 | 62,000.00 |
| Jun 30, 2024 | 66,000.00 |
| Mar 31, 2024 | 187,000.00 |
| Sep 30, 2023 | 545,000.00 |
| Jun 30, 2023 | 369,000.00 |
| Mar 31, 2023 | 414,000.00 |
| Dec 31, 2022 | 485,000.00 |
| Sep 30, 2022 | -254,000.00 |
| Jun 30, 2022 | -237,000.00 |
| Mar 31, 2022 | -1.36 Mn |
| Dec 31, 2021 | -417,000.00 |
| Jun 30, 2021 | -116,000.00 |